newsfilter
← Latest News
PR Newswire·

Medtronic announces FDA clearance for LigaSure™ RAS Maryland instrument on the Hugo™ RAS system

MDT
  • The U.S. FDA cleared the LigaSure™ RAS Maryland jaw device for use with Medtronic's Hugo™ robotic-assisted surgery system.
  • This clearance expands instrument availability on the Hugo RAS platform for U.S. surgeons performing robotic procedures.
  • LigaSure™ technology has been utilized in over 45 million surgical procedures worldwide across 65+ countries.
  • The instrument is designed exclusively for the Valleylab™ FT10 energy platform on the Hugo RAS system.
  • It seals & cuts vessels, thick tissue, & lymphatics up to 7 mm in diameter in approximately 2 seconds.
  • The device minimizes thermal spread to surrounding tissue while providing precise vessel sealing.
  • This marks the first robotic-driven LigaSure™ instrument, following its 2025 introduction in Europe.
  • The Hugo RAS system is currently cleared for urologic procedures in the U.S. with plans to expand to general & gynecologic indications.
  • Outside the U.S., the Hugo RAS system supports over 50 surgical procedures across 35+ countries.
  • Medtronic aims to provide surgeons with consistent energy instruments across open, laparoscopic, & robotic-assisted modalities.